SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as its community rallies around the project's consistent grind and recent milestones, fueled by a strong belief in its potential within the meme coin space on the Solana network. The community is actively discussing the coin's path to number one trending and eagerly anticipating upcoming utility releases, solidifying their conviction in Brokecoin's long-term prospects. With a focus on community engagement and transparency, Brokecoin aims to differentiate itself in the crowded altcoin market.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crowd is excited about Crow With Knife ($CAW.X), a meme token, with community members highlighting its fully circulated supply, active community, and multichain functionality across $SOL.X, BSC, $CRO.X, and $ETH.X. There is also discussion around its deflationary burn mechanism and partnerships.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as the community discusses its potential inclusion in the S&P 500, with the official announcement expected soon; the addition could lead to increased visibility and investment, though some investors are wary of a potential "sell the news" event. Community members are also weighing in on the platform's user experience, active trader focus, and comparison to competitors, while others are still referencing the company's involvement in the 2020 GME situation. Upcoming catalysts such as the Robinhood summit next week and anticipated Fed rate cuts are adding to the speculative buzz.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors assess its potential amid the AI-driven automation landscape, with discussions focusing on its growth prospects and recent analyst ratings. Community members are debating whether the company is undervalued, citing its strong market position and partnerships, while others express concern over insider selling and the stock's historical performance. Speculation about a potential buyout is also circulating, adding to the heightened interest in PATH.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is trending following news of an expanded collaboration with United Therapeutics to develop a second inhaled therapy, sparking enthusiasm for increased revenue potential and a strengthened partnership. The community is buzzing about the implications of this new molecule and potential future catalysts, while analysts are pointing to the expansion into pulmonary and orphan diseases as a sign of growth. Some investors speculate about a possible buyout, given the deepening relationship with United Therapeutics.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is trending due to its inclusion in the S&P 500, generating significant after-hours buzz and speculation about its future performance. While some community members are celebrating potential gains, others caution about overvaluation and potential insider selling. The inclusion has sparked discussions about the 'index effect' and its impact on the stock's trajectory.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending due to concerns and discussions surrounding a potential link between Tylenol, one of its key products, and autism, sparked by comments from RFK Jr., leading to a sharp drop and community debate on the validity of the claims and potential buying opportunities. Traders are weighing the headline risk against the company's fundamentals, resulting in high trading volume and options activity. The stock is also being discussed in the context of broader sector concerns and potential activist investor activity.

Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.

Katapult Holdings Inc

KPLT is trending due to a potential turnaround and positive Q4 performance update, with gross originations growing double-digits year-over-year. Community members are discussing the low market cap relative to revenue and comparing it to other players in the BNPL space like SEZL, with some expressing optimism for a significant price increase. Some investors are also excited about the potential for a short squeeze, and a renewed credit facility.

Ramaco Resources, Inc. engages in the operation and development of coal mining properties. The firm deals with metallurgical coal in central and southern West Virginia, southwestern Virginia and southwestern Pennsylvania. Its portfolio consists of Elk Creek, Berwind, RAM Mine, and Knox Creek. The company was founded by Randall W. Atkins in August 2015 and is headquartered in Lexington, KY.

Ramaco Resources Inc - Ordinary Shares - Class A

Ramaco Resources Inc

METC is trending as investors discuss its potential in the rare earth element (REE) market, particularly neodymium, with some highlighting its mine in Wyoming. Community members are drawing comparisons to $MP and noting the potential impact of government support and supply chain initiatives. Despite recent volatility and a pullback, the stock is seen as a long-term play, with discussions around future commercial operations and potential for significant growth in the rare earth sector.

Smith & Wesson Brands, Inc. is a holding company, which engages in the manufacture, design, and provision of firearms. Its portfolio includes handguns, long guns, handcuffs, suppressor, and other firearm-related products. The firm's brands are Smith & Wesson, M&P, Thompson/Center Arms, and Gemtech. The company was founded by Horace Smith and Daniel Baird Wesson in 1852 and is headquartered in Maryville, TN.

Smith & Wesson Brands Inc

SWBI is trending as investors assess its valuation and future prospects following earnings and recent market volatility. Community members are weighing analyst ratings, balance sheet concerns, and potential catalysts like political events and military contracts. Discussions also involve the company's dividend policy and comparisons to competitors within the firearms industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer...

Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer

Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer Flagship Pioneering Announces Two New Agreements with...

Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio

Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori...

Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner

Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as...

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence Flagship Pioneering Announces Appointment of...

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital...

Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors

Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors PR Newswire CAMBRIDGE, Mass., Oct. 3, 2024...

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore PR Newswire...

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry Flagship Pioneering Unveils Mirai Bio to Provide Fully...

GSK and Flagship Pioneering partner to discover novel medicines and vaccines

GSK and Flagship Pioneering partner to discover novel medicines and vaccines GSK and Flagship Pioneering partner to discover novel medicines and vaccines PR Newswire LONDON and CAMBRIDGE, Mass., July...

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '24	-$0.24	--	--	N/A
Q3 '24	-$0.26	-$0.30	-13.21%	MISSED
Q2 '24	-$0.37	-$0.30	17.88%	BEAT
Q1 '24	-$0.33	-$0.36	-8.15%	MISSED
Q4 '23	-$0.47	-$0.37	20.86%	BEAT

OMGA
Omega Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '24

Historical Earnings

Latest OMGA News

OMGA Omega Therapeutics Inc